Some shareholders have expressed displeasure as GlaxoSmithKline Consumer Nigeria Plc announced plans to shut down its operations in the country.
On Thursday, GSK announced through a press statement signed by their Company Secretary, Frederick Ichekwai, that it would be closing down its operations in Nigeria.
The company, whose primary activities include marketing and distribution of consumer healthcare and pharmaceutical products, said that its parent company, GSK Plc UK, had revealed its intent to cease commercialization of its prescription medicines and vaccines through its Nigerian subsidiary.
Part of the statement read, “In our published Q2 results, we disclosed that the GSK UK Group has informed GlaxoSmithKline Consumer Nigeria PLC of its strategic intent to cease commercialisation of its prescription medicines and vaccines in Nigeria through the GSK local operating companies and transition to a third-party direct distribution model for its…